I partner with visionaries that want to change the way we do medicine today. More specifically, I work with (im)patient organizations, universities and drug developers to help them develop new medicines for rare neurological diseases.

Ana Mingorance, PhD, is the Chief Development Officer of the Loulou Foundation, the Scientific Director of the Dravet Syndrome Foundation Spain, and an independent consultant in genetic epilepsy syndromes and orphan drug development. 

A neuroscientist by training, Ana first worked in drug discovery and development as a laboratory head and discovery project leader at the global pharmaceutical company UCB Pharma. She then founded her own boutique consultancy firm, Dracaena Consulting, to focus on orphan neurological diseases and to work more closely with patient organizations. Ana is a strong advocate for patient involvement in drug discovery and development, and through her roles at the Loulou Foundation and the Dravet Syndrome Foundation Spain she joins forces with the patient communities to accelerate the development of new treatments. She is also a regular speaker at rare disease and orphan drug development conferences.

Ana received her PhD in neuroscience from the University of Barcelona in Spain, and completed an EMBO postdoctoral fellowship at the University of British Columbia in Vancouver, Canada.

 


About this image:

Our background image is the Mount Teide. Standing 3718 meters tall (over 12,000 feet!), this volcano tops the island of Tenerife, in Spain. It is an exceptionally beautiful place, and it is the place that Ana calls "home".